Monitor the following:
Public Law 118-42, Consolidated Appropriations Act, 2024, Division B - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, FDA regulatory issues regarding Diagnostic Testing
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), Modernization generally
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), Modernization generally
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Duration: February 1, 2020
to
present
General Issues: Budget/Appropriations , Health Issues , Medical/Disease Research/Clinical Labs
Spending: about $500,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: House of Representatives, U.S. Senate, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Leslee K. Gilbert
Staff Director and Counsel, Committee on Science, Space & Technology; Republican Staff Director, Committee on Science & Technology; Legislative Director, Congressman Ralph M. Hall; Deputy Communications Director/Leg Asst, Congressman Ralph M. Hall
Jennifer LaTourette
Chief of Staff, Congressman Steven LaTourette; Special Assistant/Senior Legislative Assistant/Scheduler, Congressman Robert Borski; and Press Intern/Deputy Finance Director, Senator Max Baucus
Matt Henken
Legislative Director, Congressman Ed Perlmutter; Associate Staff, House Committee on Rules; and Congressional Aide, Congressman Mark Udall
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on April 19.
Original Filing: 301567167.xml
Lobbying Issues
Monitor the following:
Public Law 118-42, Consolidated Appropriations Act, 2024, Division B - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, FDA regulatory issues regarding Diagnostic Testing
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), Modernization generally
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate Executive Office of the President (EOP) Health & Human Services - Dept of (HHS)
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), Modernization generally
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Agencies Lobbied
U.S. House of Representatives U.S. Senate Executive Office of the President (EOP) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Jan. 19.
Original Filing: 301529270.xml
Lobbying Issues
H.R.4368/S.2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, FDA regulatory issues regarding Diagnostic Testing
Monitor the following:
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), generally
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
Monitor the following:
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), generally
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Oct. 19, 2023.
Original Filing: 301505833.xml
Lobbying Issues
Monitor the following:
H.R.4368/S.2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, FDA regulatory issues regarding Diagnostic Testing
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues
FDA regulation, Laboratory Testing related issues
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Pandemic All Hazards Preparedness Act, generally
Monitor the following:
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), generally
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on July 19, 2023.
Original Filing: 301481471.xml
Lobbying Issues
Monitor the following:
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Lobbying Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues
H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues
Monitor the following:
H.R.2369, VALID Act of 2023, Diagnostic Lab Testing
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), generally
Pandemic All Hazards Preparedness Act, generally
CURES 2.0, Diagnostic Lab Testing issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on April 19, 2023.
Original Filing: 301456598.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing
Laboratory Testing related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Clinical Laboratory Improvement Amendments (CLIA), generally
Pandemic All Hazards Preparedness Act, generally
Monitor CURES 2.0, Diagnostic Lab Testing issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Jan. 19, 2023.
Original Filing: 301433847.xml
Lobbying Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Lab infrastructure related issues
Public 117-180, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, Diagnostic Lab Testing related issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues
H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues
Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
Monitor the following:
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation
S.1666, VITAL Act of 2021, Diagnostic Lab Testing
H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Oct. 19, 2022.
Original Filing: 301408845.xml
Lobbying Issues
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Lab infrastructure related issues
Public 117-180, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, Diagnostic Lab Testing related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
S.1666, VITAL Act of 2021, Diagnostic Lab Testing
S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues
H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues
H.R.8188, Saving Access to Laboratory Services Act, Testing payment issues
Monitor the following:
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Highly skilled visa related issues
Public Law 117-58, Infrastructure Investment and Jobs Act, Implementation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301387537.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Lab infrastructure related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
S.1666, VITAL Act of 2021, Diagnostic Lab Testing
S.4348, Food and Drug Administration Safety and Landmark Advancements Act, Lab Develop Testing issues
H.R.7667, Food and Drug Amendments Act, Lab Develop Testing issues
Monitor the following:
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Highly skilled visa related issues
Public Law 117-58, Infrastructure Investment and Jobs Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on April 20, 2022.
Original Filing: 301364382.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023, Lab infrastructure related issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
S.1666, VITAL Act of 2021, Diagnostic Lab Testing
Monitor the following:
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Highly skilled visa related issues
Public Law 117-58, Infrastructure Investment and Jobs Act
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Jan. 19, 2022.
Original Filing: 301326565.xml
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Monitor the following:
American Jobs Plan
Highly skilled visa related issues
H.R.5376, Build Back Better Act
Public Law 117-58, Infrastructure Investment and Jobs Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
H.R.6000, CURES 2.0, Diagnostic Lab Testing issues
Monitor the following:
American Jobs Plan
Highly skilled visa related issues
H.R.5376, Build Back Better Act
Public Law 117-58, Infrastructure Investment and Jobs Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Oct. 19, 2021.
Original Filing: 301302954.xml
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
Laboratory Testing related issues
Monitor the following:
American Jobs Plan
Highly skilled visa related issues
CURES 2.0, Diagnostic Lab Testing issues
Build Back Better Act/Monitor
H.R.3684, Infrastructure Investment and Jobs Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on July 19, 2021.
Original Filing: 301279824.xml
Lobbying Issues
H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing
CURES 2.0, Diagnostic Lab Testing issues
Laboratory Testing related issues
Monitor the following:
American Jobs Plan
Highly skilled visa related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on April 19, 2021.
Original Filing: 301256705.xml
Lobbying Issues
Verifying Accurate Leading-edge IVCT Development (VALID) Act, Diagnostic Lab Testing
COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-260, Consolidated Appropriations Act, 2021
Public Law 117-2, American Rescue Plan Act of 2021
American Jobs Plan
Monitor Highly skilled visa related issues
Lobbying Issues
Verifying Accurate Leading-edge IVCT Development (VALID) Act, Diagnostic Lab Testing
COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-260, Consolidated Appropriations Act, 2021
Public Law 117-2, American Rescue Plan Act of 2021
American Jobs Plan
Monitor Highly skilled visa related issues
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234070.xml
Lobbying Issues
Monitor H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing
Monitor Highly skilled visa related issues
Monitor COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Public Law 116-139, Paycheck Protection Program and Health Care Enhancement Act
Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, Families First Coronavirus Response Act
Public Law 116-260, Consolidated Appropriations Act, 2021
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213222.xml
Lobbying Issues
H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act, COVID-19 Laboratory Testing related issues
Public Law 116-139, Paycheck Protection Program and Health Care Enhancement Act, COVID-19 Laboratory Testing related issues
Future Coronavirus relief related issues, COVID-19 Laboratory Testing related issues
Monitor COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, Families First Coronavirus Response Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301191098.xml
Lobbying Issues
H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing
COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Public Law 116-139, Paycheck Protection Program and Health Care Enhancement Act
Future Coronavirus relief related issues
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, Van Scoyoc Associates lobbied for ARUP Laboratories, Inc. , earning $20,000. The report was filed on April 17, 2020.
Original Filing: 301169051.xml
Lobbying Issues
H.R.6102, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, Diagnostic Lab Testing
COVID-19 Laboratory Testing related issues, as follows:
Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, FY2020
Public Law 116-127, Families First Coronavirus Response Act
Public Law 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs
1st Quarter, 2020
Van Scoyoc Associates filed a lobbying registration on Feb. 21, 2020 to represent ARUP Laboratories, Inc., effective Feb. 1, 2020.
Original Filing: 301142257.xml
Issue(s) they said they’d lobby about: Laboratory Diagnostic Tests (LDT) and Precision Medicine related issues .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate